Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
RCC patient and disease characteristics differ by race/ethnicity
Batai K et al. Clin Genitourin Cancer. 2018 Oct 26. doi: 10.1016/j.clgc.2018.10.012
Key clinical point: Patient and disease characteristics of RCC in a southwestern U.S. population differ by race/ethnicity.
Major finding: Compared with European Americans, Hispanic Americans and Native Americans were younger at diagnosis (55.8 and 49.7 vs. 60.5 years) and more often had clear cell histology (92.6% and 86.4% vs. 78.8%), and African Americans more often had stage III/IV disease (77.8% vs. 35.3%).
Study details: U.S. single-center retrospective cohort study of 294 patients with RCC who underwent partial or radical nephrectomy.
Disclosures: The authors declared that they did not have any conflicts of interest. The study was supported by the American Cancer Society and the Partnership for Native American Cancer Prevention.
Batai K et al. Clin Genitourin Cancer. 2018 Oct 26. doi: 10.1016/j.clgc.2018.10.012